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Letters to the Editorcaused by intraoperative factors can be
often detected between 1 and 3 days af-
ter surgery. Thereafter, theAKI ismore
likely to be attributable to postopera-
tive factors, such as hemodynamic
instability, anemia, transfusion, and
so on. Westenbrink and coworkers5
have found that postoperative anemia
is common after CABG, frequently
persists for months, and is associated
with impaired postoperative outcomes.
We therefore emphasize that efforts to
avoid the modifiable risk factors for
AKI should be continued in the postop-
erative period to prevent new AKI or
aggravation of existing kidney injury
by postoperative factors, especially
for patients who are at high risk for
AKI.
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We thank Xue and colleagues for
their interest in our publication, in
which we showed the potential
modifiable risk factors of acute kidney
injury (AKI) after coronary artery
bypass grafting.1
The focus of this study was on
studying the effects of 3 known
modifiable risk factors, the lowest
hematocrit during cardiopulmonary
bypass (CPB), preoperative anemia,
and intraoperative red blood cell
transfusion, on postoperative AKI in
our Asian patient population with
smaller average body sized. As such,
we did not look in this study
specifically at the effects of intraope-
rative hemodynamic changes and
their potentiation of hemodilutional
anemia to result in postoperative
AKI. The intraoperative systolic
blood pressure was typically main-
tained within a tight range of 100 to
130 mm Hg, however, it is likely that
a greater decrease in systolic blood
pressure would be present in hyper-
tensive patients. We also showed a
history of hypertension to be an inde-
pendent risk factor for AKI,1 albeit an
unmodifiable factor.
We are cognizant that liberal
pre-CPB crystalloid infusion may
result in hemodilution, especially for
patients with smaller body size.
Although the pre-CPB crystalloid
infusion volume was not recorded, it
was standard practice to give no
more than 1000 mL of crystalloid
before CPB.
The influences on AKI of periope-
rative medications, such as diuretics,
inotropes, statins and antiarrhythmics,
were studied. Of these, only loop
diuretics were significantly associated
with AKI in the univariate analysis
presented in our article.1 None of
the medications were independently
associated with AKI in the multi-
variate analysis.
Inour study, postoperative creatinine
measurements were done routinely in
the intensive care unit in accordanceof Thoracic and Cardiovascular Surgewith institutional protocol. Continuous
creatinine measurements were not
done. The peak serum creatinine was
the highest creatinine value obtained
within the first 3 postoperative days
and was used to calculate against the
preoperative serum creatinine to deter-
mine whether a patient had postopera-
tive AKI. AKI was defined according
to the Acute Kidney Injury Network
(AKIN) stage 1 criteria in this study.
To compare postoperative AKI
incidence with other study cohorts,
we had to use a uniform and standard
classification of AKI. Numerous
articles have used either the RIFLE
(Risk, Injury, Failure, Loss of func-
tion, and End-stage renal disease) or
AKIN criteria to define AKI. We
chose the AKIN criteria because they
account for smaller changes in serum
creatinine, which is shown to be
associated with adverse outcomes
such as mortality.2 Moreover, the
AKIN criteria use a shorter time frame
of 48 hours to assess renal function
than the RIFLE criteria, which has a
7-day window period for AKI
diagnosis.3
We found that not only was
postoperative anemia associated with
postoperative AKI, it was indepen-
dently associated with the persistence
of AKI up until hospital discharge
(unpublished data). We therefore
agree that strategies to improve
postoperative anemia can reduce the
persistence of AKI and prevent the
subsequent development of chronic
kidney disease in cardiac surgical
patients.
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SURGERY IN REPAIR
CANDIDATES JUSTIFIED?
To the Editor:
I read with great interest the report
by Sharma and colleagues1 about their
experience with aortic valve (AV)
repair and congratulate them on their
honest presentation of the long-term
data. I believe, however, that the
interpretation of some aspects needs
additional comments and questions.
The authors stated that survival after
AV repair in their population was
excellent and, with 91%, 80%, and
58% survival at 5, 10, and 15 years,
respectively, was indistinguishable
from the healthy population. Such a
survival of the healthy population
with a median age of 54 years seems
to be rather low, and this impression
could be intensified when looking at
the US Life Tables,2 which revealed
corresponding survival rates of 96%,368 The Journal of Thoracic and C90%, and 83% for a 54-year-old
population containing 76% men.
The authors found (not unexpectedly,
because this aspect has already been
revealed after AV replacement3) that
myocardial impairment (MI) was a
significant predictor of mortality.
They correctly noted that this is barely
avoidable, because the late presenta-
tion of symptoms in some patients
with aortic insufficiency does not
lead to referral for surgery until the
development of MI. They suggested,
however, earlier surgery for patients
with suitable repair anatomy. In this
context, 2 questions arise: how
reliable is the assessment of AV repair
suitability; and are patients with MI
proper candidates for AV repair? I
believe AV replacement should be
preferred for patients with consider-
able MI because such patients need a
fast and safe surgery without the risk
of residual or recurrent insufficiency,
let alone any intraoperative revisions.
The remaining aortic insufficiency,
which can never be ruled out after
repair, can even be considered as a
potential factor that can worsen long-
term survival in this special subgroup.
However, the authors did not provide
the rate of postoperative aortic insuffi-
ciency—neither in the entire nor in
this special cohort. Thus, I am
wondering whether the rate of reoper-
ation alone would be adequate enough
for assessment of clinical and, espe-
cially, functional results. Furthermore,
the number of patients operated at
Mayo Clinic, with an average of about
12 annually, does not indicate that a
considerable share of aortic valve
pathologic entities could be scheduled
for the repair. By coincidence, we
submitted an abstract for the same
American Association for Thoracic
Surgery meeting that included 137
repairs performed during a 1-year
period, but it was not well received
by the reviewers.
It seems that AV repairs are still
limited to single centers or, even, sur-
geons; hence, we can hardly speak
about the ‘‘expanding relevance ofardiovascular Surgery c July 2014AV repair.’’ The repair rate, as pre-
sented in our abstract, was 40% for
all AV surgery patients younger than
70 years or, after excluding patients
with contraindications (eg, MI), even
greater. Even if the suitability of repair
could be assessed with a probability of
about 80%, the final decision for AV
repair was always performed during
surgery. Thus, I am convinced that
AV repair is a valuable option; how-
ever, the repair candidates must fulfill
the same indication criteria as for AV
replacement,3 because the need for
replacement can never be ruled out.
Paul P. Urbanski, MD, PhD
Cardiovascular Clinic Bad Neustadt
Bad Neustadt, Germany
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THE BEST ALTERNATIVE IN
SURGERY FOR ATRIAL
FIBRILLATION
To the Editor:
We read with particular attention
the article by Stulak and colleagues.1
After close scrutiny of this report
one cannot escape the conclusion
that standard cut-and-sew Cox maze
III procedure, as first described by
Cox and associates,2 remains the cri-
terion standard choice for the surgical
treatment of any type of atrial fibrilla-
tion (AF). Of special interest is the en-
tity of mitral valve (MV) disease with
concomitant long-standing persistent
